Integrated clinicogenomic analysis reveals the evolution and metastatic tropisms of advanced colorectal cancer.
Genomic evolution in colorectal cancer drives metastatic patterns, with RAS activation increasing risk and WNT activation offering protection across sites.
- Why it matters: Understanding how genetic changes influence metastasis can improve prediction and treatment strategies for advanced CRC, addressing a critical gap in personalized oncology.
- What they did: Analyzing over 7,000 CRC samples, the study identified key genetic drivers, the timing of organ-specific metastases, and how specific genomic alterations correlate with metastatic risk.
- The result: Findings enable better prediction of metastatic sites based on tumor location and genomics, supporting targeted interventions and improved management of advanced CRC.